Published in Blood Weekly, July 17th, 2003
"Reduced immunosuppression may improve immune recovery and increase the graft-versus-leukemia effect after allogeneic stem cell transplantation," researchers in the United States explained. "Furthermore, the requirement for post-transplant immunosuppression following extensive T-cell depletion remains unclear."
S.R. Solomon and colleagues at the National Heart, Lung, and Blood Institute assessed the effects of CSA "in recipients of HLA-identical T-cell-depleted peripheral blood stem cell transplants (PBSCT), followed by donor lymphocyte...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.